Fusion in cancer: An explanatory model for aneuploidy, metastasis formation, and drug resistance

Methods in Molecular Biology

Volumn 1313, Issue , 2015, Pages 21-40

  Mohr, Marieke ^a   Zaenker, Kurt S ^a   Dittmar, Thomas ^a  

^a NONE

Author keywords

Aneuploidy; Cancer; Cell fusion; Drug resistance; Hybrid cells; Inflammation; Metastasis

Indexed keywords

ANEUPLOIDY; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL FATE; CELL FUSION; CHRONIC INFLAMMATION; HUMAN; METASTASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VIRUS INFECTION; CANCER STEM CELL; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; HYBRID CELL; INFLAMMATION; METABOLISM; NEOPLASMS; PATHOLOGY;

ANEUPLOIDY; CELL FUSION; DRUG RESISTANCE, NEOPLASM; HUMANS; HYBRID CELLS; INFLAMMATION; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84929008072     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-2703-6_2     Document Type: Article

References (140)

1. Alvarez-Dolado M, Martinez-Losa M (2011) Cell fusion and tissue regeneration. Adv Exp Med Biol 713:161
2. Quinn JM, Gillespie MT (2005) Modulation of osteoclast formation. Biochem Biophys Res Commun 328:739
3. Dittmar T, Zanker KS (2011) The fusion between the oocyte and the perm. Adv Exp Med Biol 713:1
4. Harris JR (1991) The evolution of placental mammals. FEBS Lett 295:3
5. Dittmar T, Zaenker KS (eds) (2011) Cell fusion in health and disease, vol 1. Cell fusion in health, Springer Netherlands 161–175 p 189
6. Potgens AJ, Drewlo S, Kokozidou M, Kaufmann P (2004) Syncytin: the major regulator of trophoblast fusion? Recent developments and hypotheses on its action. Hum Reprod Update 10:487
7. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R (2011) Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol 9:369
8. Aichel O (1911) Über Zellverschmelzung mit quantitativ abnormer Chromosomenvert-eilung als Ursache der Geschwulstbildung. In: Roux W (ed) Vorträge und Aufsätze über Entwicklungsmechanik der Organismen. Wilhelm Engelmann, Leipzig, Germany, pp 1–115
9. Barski G, Sorieul S, Cornefert F (1961) “Hybrid” type cells in combined cultures of two different mammalian cell strains. J Natl Cancer Inst 26:1269
10. Barski G, Cornefert F (1962) Characteristics of “hybrid”-type clonal cell lines obtained from mixed cultures in vitro. J Natl Cancer Inst 28:801
11. Barski G, Sorieul S, Cornefert F (1960) [Production of cells of a “hybrid” nature in cultures in vitro of 2 cellular strains in combination]. C R Hebd Seances Acad Sci 251:1825
12. Götz H, Goldenberg DM (1968) On the ‘human’ nature of highly malignant hetero-transplantable tumors of human origin. Eur J Cancer 4(5):547
13. Goldenberg DM, Götz H (1968) Antigenic characterization of a heterotransplanted human tumour, GW-127. Experientia 24(9): 957
14. Mekler LB, Drize OB, Osechinskii IV, Shliankevich MA (1971) [Transformation of a normal differentiated cell of an adult organism, induced by the fusion of this cell with another normal cell of the same organism but with different organ or tissue specifi city]. Vestn Akad Med Nauk SSSR 26:75
15. Chakraborty AK, de Freitas Sousa J, Espreafi co EM, Pawelek JM (2001) Human monocyte x mouse melanoma fusion hybrids express human gene. Gene 275:103
16. Rachkovsky M et al (1998) Melanoma x mac-rophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 16:299
17. Goldenberg DM (2012) Horizontal transmission of malignancy by cell-cell fusion. Expert Opin Biol Ther 12(Suppl 1):S133
18. Mi S et al (2000) Syncytin is a captive retrovi-ral envelope protein involved in human pla-cental morphogenesis. Nature 403:785
19. Bjerregard B, Ziomkiewicz I, Schulz A, Larsson LI (2014) Syncytin-1 in differentiating human myoblasts: relationship to caveo-lin- 3 and myogenin. Cell Tissue Res 357(1): 355–362
20. Soe K et al (2011) Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion. Bone 48:837
21. Loutit JF, Nisbet NW (1982) The origin of osteoclasts. Immunobiology 161:193
22. Lundberg P et al (2007) Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Biochem Biophys Res Commun 352:444
23. Kukita T et al (2004) RANKL-induced DC-STAMP is essential for osteoclastogene-sis. J Exp Med 200:941
24. Schilling AF et al (2008) Gap junctional communication in human osteoclasts in vitro and in vivo. J Cell Mol Med 12:2497
25. Bjerregaard B, Holck S, Christensen IJ, Larsson LI (2006) Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 63:1906
26. Hobolt-Pedersen AS, Delaisse JM, Soe K (2014) Osteoclast fusion is based on heterogeneity between fusion partners. Calcif Tissue Int 95:73
27. Zhou X, Platt JL (2011) Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol 713:33
28. Pajcini KV, Pomerantz JH, Alkan O, Doyonnas R, Blau HM (2008) Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J Cell Biol 180:1005
29. Davies PS, Powell AE, Swain JR, Wong MH (2009) Inflammation and proliferation act together to mediate intestinal cell fusion. PLoS One 4:e6530
30. Johansson CB et al (2008) Extensive fusion of haematopoietic cells with Purkinje neurons in response to chronic Inflammation. Nat Cell Biol 10:575
31. Nygren JM et al (2008) Myeloid and lym-phoid contribution to non-haematopoietic lineages through irradiation-induced hetero-typic cell fusion. Nat Cell Biol 10:584
32. Alvarez-Dolado M et al (2003) Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968
33. Camargo FD, Finegold M, Goodell MA (2004) Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 113:1266
34. Vassilopoulos G, Wang PR, Russell DW (2003) Transplanted bone marrow regenerates liver by cell fusion. Nature 422:901
35. Wang X et al (2003) Cell fusion is the principal source of bone-marrow-derived hepato-cytes. Nature 422:897
36. Willenbring H et al (2004) Myelomonocytic cells are suffi cient for therapeutic cell fusion in liver. Nat Med 10:744
37. Ferrand J et al (2011) Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One 6:e19569
38. Fang TC et al (2005) Proliferation of bone marrow-derived cells contributes to regeneration after folic acid-induced acute tubular injury. J Am Soc Nephrol 16:1723
39. Schmidt A, Weber OF (2006) In memoriam of Rudolf Virchow: a historical retrospective including aspects of Inflammation, infection and neoplasia. Contrib Microbiol 13:1
40. Powell AE et al (2011) Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogram-ming. Cancer Res 71:1497
41. Rizvi AZ et al (2006) Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci U S A 103:6321
42. Duelli D, Lazebnik Y (2007) Cell-to-cell fusion as a link between viruses and cancer. Nat Rev Cancer 7:968
43. Ogle BM, Cascalho M, Platt JL (2005) Biological implications of cell fusion. Nat Rev Mol Cell Biol 6:567
44. Chen EH, Grote E, Mohler W, Vignery A (2007) Cell-cell fusion. FEBS Lett 581:2181
45. zur Hausen H (2009) The search for infectious causes of human cancers: where and why (Nobel lecture). Angew Chem Int Ed Engl 48:5798
46. Sica A, Allavena P, Mantovani A (2008) Cancer related Inflammation: the macrophage connection. Cancer Lett 267:204
47. Wang IM et al (2012) Systems analysis of eleven rodent disease models reveals an infl ammatome signature and key drivers. Mol Syst Biol 8:594
48. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5:899
49. Prasad CJ, Sheets E, Selig AM, McArthur MC, Crum CP (1993) The binucleate squa-mous cell: histologic spectrum and relationship to low-grade squamous intraepithelial lesions. Mod Pathol 6(313)
50. Rappa G, Mercapide J, Lorico A (2012) Spontaneous formation of tumorigenic hybrids between breast cancer and multipo-tent stromal cells is a source of tumor heterogeneity. Am J Pathol 180:2504
51. Dittmar T et al (2011) Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis 28:75
52. Pagano JS et al (2004) Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol 14:453
53. Grace VM, Shalini JV, Lekha TT, Devaraj SN, Devaraj H (2003) Co-overexpression of p53 and bcl-2 proteins in HPV-induced squamous cell carcinoma of the uterine cervix. Gynecol Oncol 91(51)
54. Mehes G, Speich N, Bollmann M, Bollmann R (2004) Chromosomal aberrations accumulate in polyploid cells of high-grade squamous intraepithelial lesions (HSIL). Pathol Oncol Res 10:142
55. Goldenberg DM et al (2012) Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer 131:49
56. Moscatelli I et al (2013) Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis. Bone 57:1
57. Mertens F, Johansson B, Hoglund M, Mitelman F (1997) Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 57:2765
58. Duelli D, Lazebnik Y (2003) Cell fusion: a hidden enemy? Cancer Cell 3:445
59. Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17:157
60. Storchova Z, Kuffer C (2008) The consequences of tetraploidy and aneuploidy. J Cell Sci 121:3859
61. Lv L et al (2012) Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells. Cell Cycle 11:2864
62. Vitale I et al (2011) Illicit survival of cancer cells during polyploidization and depoly-ploidization. Cell Death Differ 18:1403
63. Davoli T, de Lange T (2012) Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21:765
64. Duncan AW et al (2009) Ploidy reductions in murine fusion-derived hepatocytes. PLoS Genet 5:e1000385
65. Boveri T (1914) Zur Frage der Entstenhung Maligner Tumoren. Gustav Fischer, Jena, Germany
66. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC (2001) Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 61:8838
67. Duesberg P, Rausch C, Rasnick D, Hehlmann R (1998) Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci U S A 95:13692
68. Holland AJ, Cleveland DW (2012) Losing balance: the origin and impact of aneuploidy in cancer. EMBO Rep 13:501
69. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P (2000) Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy. Proc Natl Acad Sci U S A 97:3236
70. Duesberg P (1999) Are centrosomes or aneu-ploidy the key to cancer? Science 284:2091
71. Rasnick D, Duesberg PH (1999) How aneu-ploidy affects metabolic control and causes cancer. Biochem J 340(Pt 3):621
72. Sheltzer JM et al (2011) Aneuploidy drives genomic instability in yeast. Science 333:1026
73. Niwa O, Tange Y, Kurabayashi A (2006) Growth arrest and chromosome instability in aneuploid yeast. Yeast 23:937
74. Segal DJ, McCoy EE (1974) Studies on Down’s syndrome in tissue culture. I. Growth rates and protein contents of fi broblast cultures. J Cell Physiol 83:85
75. Thorburn RR et al (2013) Aneuploid yeast strains exhibit defects in cell growth and passage through START. Mol Biol Cell 24:1274
76. Torres EM et al (2007) Effects of aneuploidy on cellular physiology and cell division in hap-loid yeast. Science 317:916
77. Silk AD et al (2013) Chromosome missegre-gation rate predicts whether aneuploidy will promote or suppress tumors. Proc Natl Acad Sci U S A 110:E4134
78. Klein G, Bregula U, Wiener F, Harris H (1971) The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci 8:659
79. Harris H, Bregula U, Klein G (1971) The analysis of malignancy by cell fusion. II. Hybrids between Ehrlich cells and normal diploid cells. J Cell Sci 8:673
80. Harris H, Wiener F, Klein G (1971) The analysis of malignancy by cell fusion. 3. Hybrids between diploid fi broblasts and other tumour cells. J Cell Sci 8:681
81. Yap TA, Gerlinger M, Futreal PA, Pusztai L, Swanton C (2012) Intratumor heterogeneity: seeing the wood for the trees. Sci Transl Med 4:127ps10
82. Greaves M, Maley CC (2012) Clonal evolution in cancer. Nature 481:306
83. Gerlinger M et al (2012) Intratumor heterogeneity and branched evolution revealed by mul-tiregion sequencing. N Engl J Med 366:883
84. Mullighan CG et al (2008) Genomic analysis of the clonal origins of relapsed acute lym-phoblastic leukemia. Science 322:1377
85. Wu X et al (2012) Clonal selection drives genetic divergence of metastatic medulloblas-toma. Nature 482:529
86. Jacobsen BM et al (2006) Spontaneous fusion with, and transformation of mouse stroma by, malignant human breast cancer epithelium. Cancer Res 66:8274
87. Dittmar T et al (2009) Recurrence cancer stem cells–made by cell fusion? Med Hypotheses 73:542
88. Nagler C, Hardt C, Zanker KS, Dittmar T (2011) Co-cultivation of murine BMDCs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant cells. Cancer Cell Int 11:21
89. Duncan AW et al (2010) The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 467:707
90. Goldenberg DM, Pavia RA, Tsao MC (1974) In vivo hybridisation of human tumour and normal hamster cells. Nature 250:649
91. Andersen TL et al (2007) Osteoclast nuclei of myeloma patients show chromosome translo-cations specifi c for the myeloma cell clone: a new type of cancer-host partnership? J Pathol 211:10
92. Lu X, Kang Y (2009) Effi cient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci U S A 106:9385
93. Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742
94. Fidler IJ (2003) The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer 3:453
95. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563
96. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265
97. Trimboli AJ et al (2008) Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 68:937
98. Pinkas J, Leder P (2002) MEK1 signaling mediates transformation and metastasis of EpH4 mammary epithelial cells independent of an epithelial to mesenchymal transition. Cancer Res 62:4781
99. Tarin D, Thompson EW, Newgreen DF (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65:5996
100. Pawelek JM, Chakraborty AK (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8:377
101. Pawelek JM, Chakraborty AK (2008) The cancer cell–leukocyte fusion theory of metastasis. Adv Cancer Res 101:397
102. Chakraborty AK et al (2001) Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis. Cell Growth Differ 12:623
103. Martin-Padura I et al (2012) Spontaneous cell fusion of acute leukemia cells and macro-phages observed in cells with leukemic potential. Neoplasia 14:1057
104. Sodi SA et al (1998) Melanoma x macro-phage fusion hybrids acquire increased mela-nogenesis and metastatic potential: altered N-glycosylation as an underlying mechanism. Pigment Cell Res 11:299
105. Chakraborty AK et al (2000) A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 60:2512
106. Pawelek JM et al (1999) Altered N-glycosylation in macrophage x melanoma fusion hybrids. Cell Mol Biol 45:1011
107. Rachkovsky M, Pawelek J (1999) Acquired melanocyte stimulating hormone-inducible chemotaxis following macrophage fusion with Cloudman S91 melanoma cells. Cell Growth Differ 10:517
108. Dittmar T, Nagler C, Niggemann B, Zanker KS (2013) The dark side of stem cells: triggering cancer progression by cell fusion. Curr Mol Med 13:735
109. Berndt B et al (2013) Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines. PLoS One 8:e63711
110. Goldenberg DM et al (2013) Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One 8: e55324
111. Li H et al (2014) Fusion of HepG2 cells with mesenchymal stem cells increases cancer associated and malignant properties: an in vivo metastasis model. Oncol Rep 32(2): 539–547
112. Marcato P et al (2011) Aldehyde dehydroge-nase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29:32
113. Podhajcer OL et al (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27:691
114. Lazova R et al (2013) A melanoma brain metastasis with a donor-patient hybrid genome following bone marrow transplantation: fi rst evidence for fusion in human cancer. PLoS One 8:e66731
115. Miller FR, Mohamed AN, McEachern D (1989) Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res 49:4316
116. Yang JY, Ha SA, Yang YS, Kim JW (2010) p-Glycoprotein ABCB5 and YB-1 expression plays a role in increased heterogeneity of breast cancer cells: correlations with cell fusion and doxorubicin resistance. BMC Cancer 10:388
117. Frank NY et al (2003) Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J Biol Chem 278:47156
118. Hembruff SL et al (2008) Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance. BMC Cancer 8:318
119. Clarke MF et al (2006) Cancer stem cells– perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339
120. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105
121. Li F, Tiede B, Massague J, Kang Y (2007) Beyond tumorigenesis: cancer stem cells in metastasis. Cell Res 17:3
122. Croker AK, Allan AL (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease. J Cell Mol Med 12:374
123. Croker AK et al (2009) High aldehyde dehy-drogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 13:2236
124. Hermann PC et al (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1:313
125. Nagler C, Zanker KS, Dittmar T (2011) Cell fusion, drug resistance and recurrence CSCs. Adv Exp Med Biol 714:173
126. Eyler CE, Rich JN (2008) Survival of the fi t-test: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 26:2839
127. Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67:8980
128. Dean M, Fojo T, Bates S (2005) Tumour stem cells and drug resistance. Nat Rev Cancer 5:275
129. Shervington A, Lu C (2008) Expression of multidrug resistance genes in normal and cancer stem cells. Cancer Invest 26:535
130. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identifi cation of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100:3983
131. Li C et al (2007) Identifi cation of pancreatic cancer stem cells. Cancer Res 67:1030
132. Masters JR, Koberle B (2003) Curing meta-static cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 3:517
133. Shackleton M, Quintana E, Fearon ER, Morrison SJ (2009) Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 138:822
134. Goldenberg DM, Bhan RD, Pavia RA (1971) In vivo human-hamster somatic cell fusion indicated by glucose 6-phosphate dehydroge-nase and lactate dehydrogenase profi les. Cancer Res 31:1148
135. Busund LT, Killie MK, Bartnes K, Seljelid R (2002) Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor. Int J Cancer 100:407
136. Duelli DM, Lazebnik YA (2000) Primary cells suppress oncogene-dependent apoptosis. Nat Cell Biol 2:859
137. Nagler C, Zänker KS, Dittmar T (2010) Murine breast-cancer-cell/mesenchymal-stem- cell hybrids exhibit enhanced drug resistance to different cytostatic drugs. J Stem Cells Regen Med 6:133
138. Blagosklonny MV (2005) Why therapeutic response may not prolong the life of a cancer patient: selection for oncogenic resistance. Cell Cycle 4:1693
139. Shafee N et al (2008) Cancer stem cells contribute to cisplatin resistance in Brca1/ p53-mediated mouse mammary tumors. Cancer Res 68:3243
140. Ding J, Jin W, Chen C, Shao Z, Wu J (2012) Tumor associated macrophage x cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 7:e41942